Extension feasbility study to Germany

Posted on 01 October 2019

Share this newsmessage
Extension feasbility study to Germany

Lyncoclinical's services has just been expanded for this first in human study. 

One location in Belgium was closed, yet the study was extended to include four locations in Germany. Lyncoclinical will serve as the sponsor's representative, advising and representing the sponsor from Israel to the Belgium FAGG and the German competent authority.

Furthermore, we set up the sites, monitor it, and assist the site research teams.